6 Comments

Jesus christ, what a write-up, gonna share this on Sunday, thanks.

Expand full comment
Aug 1, 2022Liked by Devin LaSarre

This is a great write-up; I largely agree with everything here. Only issue I worry about is management. You touched on it in risks, but it's a bigger concern than one paragraph. This is a company that's been run by the same group of insiders for decades. They're fantastic at running a cigarette company. There's no evidence that they have any clue how to do anything else. Every Altria bull-case relies on assuming that they'll be able to capitalize on their position. Which I agree is very strong. They *should* have an easy path to transition into the new product areas you talked about. But capitalizing requires making good decisions. So far, that hasn't happened. If they'd done one thing to indicate that they have a coherent forward-looking strategy beyond "fuck it, we've got 100 billion dollars, we'll figure it out" MO would be like 40% or more of my portfolio right now.

Basically, the question is whether Altria is Yahoo or Microsoft. Right now it looks ominously like Yahoo.

Expand full comment

How are you incorporating recent administration proposal on max nicotine levels? I know the proposal isn't until May 2023 and could very well extend beyond that with actual implications taking over 5years to actually do anything. Read your post on the JUUL news which I agree with though the market is hammering $MO as if it's a huge chunk of their business that they already haven't written down dramatically.

Expand full comment